These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11329055)

  • 21. Hereditary breast cancer.
    Hill A; McDermott E; O'Higgins N
    Br J Surg; 1998 Aug; 85(8):1157. PubMed ID: 9718021
    [No Abstract]   [Full Text] [Related]  

  • 22. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.
    Le Page F; Randrianarison V; Marot D; Cabannes J; Perricaudet M; Feunteun J; Sarasin A
    Cancer Res; 2000 Oct; 60(19):5548-52. PubMed ID: 11034101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic risk of breast cancer.
    Nasir A; Shackelford RE; Anwar F; Yeatman TJ
    Minerva Endocrinol; 2009 Dec; 34(4):295-309. PubMed ID: 20046159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRCA1/BRCA2 in breast-conserving therapy.
    Turner BC; Glazer PM; Haffty BG
    J Clin Oncol; 1999 Nov; 17(11):3689. PubMed ID: 10550169
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene-expression profiles in hereditary breast cancer.
    Sudbø J; Reith A; Lingjaerde OC
    N Engl J Med; 2001 Jun; 344(26):2029. PubMed ID: 11430338
    [No Abstract]   [Full Text] [Related]  

  • 26. Roads leading to breast cancer.
    Haber D
    N Engl J Med; 2000 Nov; 343(21):1566-8. PubMed ID: 11087889
    [No Abstract]   [Full Text] [Related]  

  • 27. BRCA: the breast, ovarian, and other cancer genes.
    Boyd J
    Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
    Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
    Healey CS; Dunning AM; Teare MD; Chase D; Parker L; Burn J; Chang-Claude J; Mannermaa A; Kataja V; Huntsman DG; Pharoah PD; Luben RN; Easton DF; Ponder BA
    Nat Genet; 2000 Nov; 26(3):362-4. PubMed ID: 11062481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex steroid hormones and genetic susceptibility to breast and prostate cancer.
    Feigelson HS; Ross RK; Yu MC; Coetzee GA; Reichardt JK; Henderson BE
    Drug Metab Rev; 1998 May; 30(2):421-34. PubMed ID: 9606611
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18. Genetics of breast cancer.
    Irving M; Elmslie F; Berg J
    Int J Clin Pract; 2002 Nov; 56(9):677-82. PubMed ID: 12469982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics of breast cancer: can we use today's information?
    Bell NN
    Manag Care Interface; 1998 May; 11(5):52-6. PubMed ID: 10181553
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.